Skip to main content
Top
Published in: Journal of Translational Medicine 1/2016

Open Access 01-12-2016 | Research

Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema

Authors: Anna Salazar-Degracia, David Blanco, Mònica Vilà-Ubach, Gabriel de Biurrun, Carlos Ortiz de Solórzano, Luis M. Montuenga, Esther Barreiro

Published in: Journal of Translational Medicine | Issue 1/2016

Login to get access

Abstract

Background

Muscle wasting negatively impacts the progress of chronic diseases such as lung cancer (LC) and emphysema, which are in turn interrelated.

Objectives

We hypothesized that muscle atrophy and body weight loss may develop in an experimental mouse model of lung carcinogenesis, that the profile of alterations in muscle fiber phenotype (fiber type composition and morphometry, muscle structural alterations, and nuclear apoptosis), and in muscle metabolism are similar in both respiratory and limb muscles of the tumor-bearing mice, and that the presence of underlying emphysema may influence those events.

Methods

Diaphragm and gastrocnemius muscles of mice with urethane-induced lung cancer (LC-U) with and without elastase-induced emphysema (E–U) and non-exposed controls (N = 8/group) were studied: fiber type composition, morphometry, muscle abnormalities, apoptotic nuclei (immunohistochemistry), and proteolytic and autophagy markers (immunoblotting) at 20- and 35-week exposure times. In the latter cohort, structural contractile proteins, creatine kinase (CK), peroxisome proliferator-activated receptor (PPAR) expression, oxidative stress, and inflammation were also measured. Body and muscle weights were quantified (baseline, during follow-up, and sacrifice).

Results

Compared to controls, in U and E–U mice, whole body, diaphragm and gastrocnemius weights were reduced. Additionally, both in diaphragm and gastrocnemius, muscle fiber cross-sectional areas were smaller, structural abnormalities, autophagy and apoptotic nuclei were increased, while levels of actin, myosin, CK, PPARs, and antioxidants were decreased, and muscle proteolytic markers did not vary among groups.

Conclusions

In this model of lung carcinogenesis with and without emphysema, reduced body weight gain and muscle atrophy were observed in respiratory and limb muscles of mice after 20- and 35-week exposure times most likely through increased nuclear apoptosis and autophagy. Underlying emphysema induced a larger reduction in the size of slow- and fast-twitch fibers in the diaphragm of U and E–U mice probably as a result of the greater inspiratory burden imposed onto this muscle.
Appendix
Available only for authorised users
Literature
4.
6.
go back to reference Barreiro E, Puig-Vilanova E, Marin-Corral J, Chacon-Cabrera A, Salazar-Degracia A, Mateu X, et al. Therapeutic approaches in mitochondrial dysfunction, proteolysis, and structural alterations of diaphragm and gastrocnemius in rats with chronic heart failure. J Cell Physiol. 2015. doi:10.1002/jcp.25241.PubMed Barreiro E, Puig-Vilanova E, Marin-Corral J, Chacon-Cabrera A, Salazar-Degracia A, Mateu X, et al. Therapeutic approaches in mitochondrial dysfunction, proteolysis, and structural alterations of diaphragm and gastrocnemius in rats with chronic heart failure. J Cell Physiol. 2015. doi:10.​1002/​jcp.​25241.PubMed
7.
go back to reference Chacon-Cabrera A, Fermoselle C, Urtreger AJ, Mateu-Jimenez M, Diament MJ, de Kier Joffe ED, et al. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness. J Cell Physiol. 2014;229(11):1660–72. doi:10.1002/jcp.24611.CrossRefPubMed Chacon-Cabrera A, Fermoselle C, Urtreger AJ, Mateu-Jimenez M, Diament MJ, de Kier Joffe ED, et al. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness. J Cell Physiol. 2014;229(11):1660–72. doi:10.​1002/​jcp.​24611.CrossRefPubMed
8.
go back to reference Chacon-Cabrera A, Fermoselle C, Salmela I, Yelamos J, Barreiro E. MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(−/−) and Parp-2(−/−) mice with lung cancer cachexia. Biochim Biophys Acta. 2015;1850(12):2530–43. doi:10.1016/j.bbagen.2015.09.020.CrossRefPubMed Chacon-Cabrera A, Fermoselle C, Salmela I, Yelamos J, Barreiro E. MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(−/−) and Parp-2(−/−) mice with lung cancer cachexia. Biochim Biophys Acta. 2015;1850(12):2530–43. doi:10.​1016/​j.​bbagen.​2015.​09.​020.CrossRefPubMed
10.
go back to reference Fermoselle C, Garcia-Arumi E, Puig-Vilanova E, Andreu AL, Urtreger AJ, de Kier Joffe ED, et al. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice. Exp Physiol. 2013;98(9):1349–65. doi:10.1113/expphysiol.2013.072496.CrossRefPubMed Fermoselle C, Garcia-Arumi E, Puig-Vilanova E, Andreu AL, Urtreger AJ, de Kier Joffe ED, et al. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice. Exp Physiol. 2013;98(9):1349–65. doi:10.​1113/​expphysiol.​2013.​072496.CrossRefPubMed
11.
go back to reference Marin-Corral J, Fontes CC, Pascual-Guardia S, Sanchez F, Olivan M, Argiles JM, et al. Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid Redox Signal. 2010;12(3):365–80.CrossRefPubMed Marin-Corral J, Fontes CC, Pascual-Guardia S, Sanchez F, Olivan M, Argiles JM, et al. Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid Redox Signal. 2010;12(3):365–80.CrossRefPubMed
12.
go back to reference Argiles JM, Lopez-Soriano FJ. The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci. 1996;17(6):223–6.CrossRefPubMed Argiles JM, Lopez-Soriano FJ. The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci. 1996;17(6):223–6.CrossRefPubMed
17.
go back to reference Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, Hussain SN, Gea J, Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J. 2009;33(6):1309–19.CrossRefPubMed Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, Hussain SN, Gea J, Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J. 2009;33(6):1309–19.CrossRefPubMed
18.
go back to reference Puig-Vilanova E, Martinez-Llorens J, Ausin P, Roca J, Gea J, Barreiro E. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD. Clin Sci (Lond). 2015;128(12):905–21. doi:10.1042/CS20140428.CrossRef Puig-Vilanova E, Martinez-Llorens J, Ausin P, Roca J, Gea J, Barreiro E. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD. Clin Sci (Lond). 2015;128(12):905–21. doi:10.​1042/​CS20140428.CrossRef
19.
20.
go back to reference Remels AH, Gosker HR, Schrauwen P, Hommelberg PP, Sliwinski P, Polkey M, et al. TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J. 2010;24(12):5052–62. doi:10.1096/fj.09-150714.CrossRefPubMed Remels AH, Gosker HR, Schrauwen P, Hommelberg PP, Sliwinski P, Polkey M, et al. TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J. 2010;24(12):5052–62. doi:10.​1096/​fj.​09-150714.CrossRefPubMed
21.
go back to reference Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996;153(1):288–93. doi:10.1164/ajrccm.153.1.8542131.CrossRefPubMed Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996;153(1):288–93. doi:10.​1164/​ajrccm.​153.​1.​8542131.CrossRefPubMed
22.
go back to reference Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Belanger M, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax. 2000;55(10):848–53.CrossRefPubMedPubMedCentral Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Belanger M, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax. 2000;55(10):848–53.CrossRefPubMedPubMedCentral
23.
go back to reference Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, et al. An Official American Thoracic Society/European Respiratory Society Statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–62. doi:10.1164/rccm.201402-0373ST.CrossRefPubMedPubMedCentral Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, et al. An Official American Thoracic Society/European Respiratory Society Statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–62. doi:10.​1164/​rccm.​201402-0373ST.CrossRefPubMedPubMedCentral
24.
25.
go back to reference Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax. 2008;63(2):100–7.CrossRefPubMed Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax. 2008;63(2):100–7.CrossRefPubMed
26.
go back to reference Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, Sanchez F, et al. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med. 2010;182(4):477–88.CrossRefPubMed Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, Sanchez F, et al. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med. 2010;182(4):477–88.CrossRefPubMed
27.
28.
29.
go back to reference Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(10):1116–24. doi:10.1164/rccm.200407-887OC.CrossRefPubMed Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(10):1116–24. doi:10.​1164/​rccm.​200407-887OC.CrossRefPubMed
31.
go back to reference Barreiro E, Gea J, Matar G, Hussain SN. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2005;33(6):636–42. doi:10.1165/rcmb.2005-0114OC.CrossRefPubMed Barreiro E, Gea J, Matar G, Hussain SN. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2005;33(6):636–42. doi:10.​1165/​rcmb.​2005-0114OC.CrossRefPubMed
32.
go back to reference Artaechevarria X, Blanco D, de Biurrun G, Ceresa M, Perez-Martin D, Bastarrika G, et al. Evaluation of micro-CT for emphysema assessment in mice: comparison with non-radiological techniques. Eur Radiol. 2011;21(5):954–62. doi:10.1007/s00330-010-1982-5.CrossRefPubMed Artaechevarria X, Blanco D, de Biurrun G, Ceresa M, Perez-Martin D, Bastarrika G, et al. Evaluation of micro-CT for emphysema assessment in mice: comparison with non-radiological techniques. Eur Radiol. 2011;21(5):954–62. doi:10.​1007/​s00330-010-1982-5.CrossRefPubMed
35.
go back to reference de-Torres JP, Wilson DO, Sanchez-Salcedo P, Weissfeld JL, Berto J, Campo A, et al. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD lung cancer screening score. Am J Respir Crit Care Med. 2015;191(3):285–91. doi:10.1164/rccm.201407-1210OC.CrossRefPubMedPubMedCentral de-Torres JP, Wilson DO, Sanchez-Salcedo P, Weissfeld JL, Berto J, Campo A, et al. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD lung cancer screening score. Am J Respir Crit Care Med. 2015;191(3):285–91. doi:10.​1164/​rccm.​201407-1210OC.CrossRefPubMedPubMedCentral
36.
37.
39.
go back to reference Sanchez-Salcedo P, Wilson DO, de-Torres JP, Weissfeld JL, Berto J, Campo A, et al. Improving selection criteria for lung cancer screening. The potential role of emphysema. Am J Respir Crit Care Med. 2015;191(8):924–31. doi:10.1164/rccm.201410-1848OC.CrossRefPubMed Sanchez-Salcedo P, Wilson DO, de-Torres JP, Weissfeld JL, Berto J, Campo A, et al. Improving selection criteria for lung cancer screening. The potential role of emphysema. Am J Respir Crit Care Med. 2015;191(8):924–31. doi:10.​1164/​rccm.​201410-1848OC.CrossRefPubMed
40.
go back to reference Miravitlles M, Worth H, Soler-Cataluna JJ, Price D, De Benedetto F, Roche N, et al. The relationship between 24-hour symptoms and COPD exacerbations and healthcare resource use: results from an observational study (ASSESS). COPD. 2016;1–8. doi: 10.3109/15412555.2016.1150447. Miravitlles M, Worth H, Soler-Cataluna JJ, Price D, De Benedetto F, Roche N, et al. The relationship between 24-hour symptoms and COPD exacerbations and healthcare resource use: results from an observational study (ASSESS). COPD. 2016;1–8. doi: 10.​3109/​15412555.​2016.​1150447.
43.
go back to reference Munoz-Barrutia A, Ceresa M, Artaechevarria X, Montuenga LM, Ortiz-de-Solorzano C. Quantification of lung damage in an elastase-induced mouse model of emphysema. Int J Biomed Imaging. 2012;2012:734734. doi:10.1155/2012/734734.CrossRefPubMed Munoz-Barrutia A, Ceresa M, Artaechevarria X, Montuenga LM, Ortiz-de-Solorzano C. Quantification of lung damage in an elastase-induced mouse model of emphysema. Int J Biomed Imaging. 2012;2012:734734. doi:10.​1155/​2012/​734734.CrossRefPubMed
45.
go back to reference Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametller E, et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res. 2004;64(18):6725–31.CrossRefPubMed Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametller E, et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res. 2004;64(18):6725–31.CrossRefPubMed
48.
49.
go back to reference Slot IG, Schols AM, de Theije CC, Snepvangers FJ, Gosker HR. Alterations in skeletal muscle oxidative phenotype in mice exposed to 3 weeks of normobaric hypoxia. J Cell Physiol. 2016;231(2):377–92. doi:10.1002/jcp.25083.CrossRefPubMed Slot IG, Schols AM, de Theije CC, Snepvangers FJ, Gosker HR. Alterations in skeletal muscle oxidative phenotype in mice exposed to 3 weeks of normobaric hypoxia. J Cell Physiol. 2016;231(2):377–92. doi:10.​1002/​jcp.​25083.CrossRefPubMed
50.
go back to reference Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84(2–3):275–94.CrossRefPubMed Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84(2–3):275–94.CrossRefPubMed
51.
go back to reference Lexell J, Downham D. What is the effect of ageing on type 2 muscle fibres? J Neurol Sci. 1992;107(2):250–1.CrossRefPubMed Lexell J, Downham D. What is the effect of ageing on type 2 muscle fibres? J Neurol Sci. 1992;107(2):250–1.CrossRefPubMed
52.
go back to reference Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995;50((Spec No)):11–6.PubMed Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995;50((Spec No)):11–6.PubMed
53.
go back to reference Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, et al. Peroxisome proliferator-activated receptor-gamma co-activator 1α-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 2005;280(39):33588–98. doi:10.1074/jbc.M507621200.CrossRefPubMed Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, et al. Peroxisome proliferator-activated receptor-gamma co-activator 1α-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 2005;280(39):33588–98. doi:10.​1074/​jbc.​M507621200.CrossRefPubMed
54.
go back to reference Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, et al. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 2003;17(15):2299–301. doi:10.1096/fj.03-0269fje.PubMed Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, et al. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 2003;17(15):2299–301. doi:10.​1096/​fj.​03-0269fje.PubMed
55.
56.
go back to reference Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(12):1664–9.CrossRefPubMed Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(12):1664–9.CrossRefPubMed
57.
go back to reference Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2004;169(9):1022–7.CrossRefPubMed Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2004;169(9):1022–7.CrossRefPubMed
58.
go back to reference Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, Gea J, et al. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med. 2012;52(1):88–94.CrossRefPubMed Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, Gea J, et al. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med. 2012;52(1):88–94.CrossRefPubMed
59.
go back to reference Jiang Z, Lao T, Qiu W, Polverino F, Gupta K, Guo F, et al. A chronic obstructive pulmonary disease susceptibility gene, FAM13A, regulates protein stability of β-catenin. Am J Respir Crit Care Med. 2016. doi:10.1164/rccm.201505-0999OC.PubMed Jiang Z, Lao T, Qiu W, Polverino F, Gupta K, Guo F, et al. A chronic obstructive pulmonary disease susceptibility gene, FAM13A, regulates protein stability of β-catenin. Am J Respir Crit Care Med. 2016. doi:10.​1164/​rccm.​201505-0999OC.PubMed
60.
go back to reference Kai Y, Tomoda K, Yoneyama H, Yoshikawa M, Kimura H. RNA interference targeting carbohydrate sulfotransferase 3 diminishes macrophage accumulation, inhibits MMP-9 expression and promotes lung recovery in murine pulmonary emphysema. Respir Res. 2015;16(1):146. doi:10.1186/s12931-015-0310-7.CrossRefPubMedPubMedCentral Kai Y, Tomoda K, Yoneyama H, Yoshikawa M, Kimura H. RNA interference targeting carbohydrate sulfotransferase 3 diminishes macrophage accumulation, inhibits MMP-9 expression and promotes lung recovery in murine pulmonary emphysema. Respir Res. 2015;16(1):146. doi:10.​1186/​s12931-015-0310-7.CrossRefPubMedPubMedCentral
Metadata
Title
Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema
Authors
Anna Salazar-Degracia
David Blanco
Mònica Vilà-Ubach
Gabriel de Biurrun
Carlos Ortiz de Solórzano
Luis M. Montuenga
Esther Barreiro
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2016
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-016-1003-9

Other articles of this Issue 1/2016

Journal of Translational Medicine 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.